comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 21:07:03 - browse：7

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Drug companies' payments and gifts affect physicians' prescribing

explore

WSS

Medicare Advantage 2025 payments will dip, Biden administration says

Intermittent fasting comes with a heart risk? Not so fast

U.K. decision on ALS drug has neurologists, advocates up in arms

Researchers test human milk's ability to repair gut microbiome

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Overprescribed: High cost isn't America's only drug problem

focus

comprehensive

explore

In Memoriam: Notable people who died in 2023

Plastic surgeons increase patient psychiatric screenings

Virginia high school admissions case could be legal follow

Scientific mystery highlights the blind spots in genomics databases

How to save PrEP access — and even expand it

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

How one medical school became remarkably diverse

Pancreatic cancer is often deadly, but new discoveries are raising hope

Heart attack and stroke risk calculators need revising

SCOTUS questions limit to govt efforts to fight misinformation

entertainment

Nurses recount patients attacks

Neuroscience’s long legacy of racism

Covid silver lining: Unprecedented look at human immune system

Florida Supreme Court upholds state's abortion ban

Overprescribed: High cost isn't America's only drug problem

Insurer loopholes limit power of law against surprise medical bills

hotspot

explore

Wikipedia

hotspot